skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > halide > organohalogen compound > organofluorine compound > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > aromatic amide > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > aromatic amide > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > aromatic amide > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > aromatic amide > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > carbocyclic compound > cyclopropanes > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > carbocyclic compound > cyclopropanes > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > carbocyclic compound > cyclopropanes > n-/{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl/}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide > trans-(1s,2r)-sedaxane

Preferred term

trans-(1s,2r)-sedaxane  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C18H19F2N3O

inchi

  • InChI=1S/C18H19F2N3O/c1-23-9-14(16(22-23)17(19)20)18(24)21-15-5-3-2-4-11(15)13-8-12(13)10-6-7-10/h2-5,9-10,12-13,17H,6-8H2,1H3,(H,21,24)/t12-,13-/m0/s1

inchikey

  • XQJQCBDIXRIYRP-STQMWFEESA-N

is_enantiomer_of

mass

  • 331.35980

monoisotopicmass

  • 331.14962

smiles

  • Cn1cc(C(=O)Nc2ccccc2[C@@H]2C[C@H]2C2CC2)c(n1)C(F)F

subset

  • 3_STAR

synonym EXACT

  • N-{2-[(1S,2R)-1,1'-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:83178

Download this concept:

RDF/XML TURTLE JSON-LD